Skip to main content
HCPCS Level II/J-Codes/J2785

J2785 HCPCS Level II Code: Injection, regadenoson, 0.1 mg

Medicare Coverage & Payment

  • Medicare coverage: Carrier judgment (CMS coverage code C)
  • Payment category: Drugs (pricing indicator 51)
  • BETOS: O1E — Other drugs
  • Last CMS action effective: January 1, 2014

Source: CMS HCPCS Level II release. Coverage codes indicate how Medicare treats the code, not whether a specific claim will be paid; payer policy and documentation still govern.

Official Registry Overview & Definition

Injection, regadenoson, 0.1 mg is a HCPCS Level II code (J2785). CMS assigns coverage code C — Carrier judgment. Short description: Regadenoson injection.

Nearest Codes in This Family

Official HCPCS Level II classifications closest to J2785 in its code family, with their registry titles.

  • J2779 — Injection, ranibizumab, via intravitreal implant (susvimo), 0.1 mg
  • J2780 — Injection, ranitidine hydrochloride, 25 mg
  • J2781 — Injection, pegcetacoplan, intravitreal, 1 mg
  • J2782 — Injection, avacincaptad pegol, 0.1 mg
  • J2783 — Injection, rasburicase, 0.5 mg
  • J2786 — Injection, reslizumab, 1 mg
  • J2787 — Riboflavin 5'-phosphate, ophthalmic solution (photrexa viscous/photrexa), up to 3 ml
  • J2788 — Injection, rho d immune globulin, human, minidose, 50 micrograms (250 i.u.)
  • J2789 — Riboflavin 5'-phosphate, ophthalmic solution (epioxahd/epioxa), up to 2 ml
  • J2790 — Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)